Ian Lyons
University of Adelaide
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ian Lyons.
Transplantation | 1996
Rick G. Tearle; Margaret J. Tange; Zara L. Zannettino; Marina Katerelos; Trixie A. Shinkel; Bryce J. W. van Denderen; Andrew Lonie; Ian Lyons; Mark B. Nottle; Timothy Cox; Christiane Becker; Anita M. Peura; Peter L. Wigley; Robert J. Crawford; Allan J. Robins; Martin J. Pearse; Anthony J. F. d'Apice
Organ xenografts in discordant combinations such as pig-to-man undergo hyperacute rejection due to the presence of naturally occurring human anti-pig xenoantibodies. The galactose alpha(1,3)-galactose epitope on glycolipids and glycoproteins is the major porcine xenoantigen recognized by these xenoantibodies. This epitope is formed by alpha(1,3)-galactosyltransferase, which is present in all mammals except man, apes, and Old World monkeys. We have generated mice lacking this major xenoantigen by inactivating the alpha(1,3)-galactosyltransferase gene. These mice are viable and have normal organs but develop cataracts. Substantially less xenoantibody from human serum binds to cells and tissues of these mice compared with normal mice. Similarly, there is less activation of human complement on cells from mice lacking the galactose alpha(1,3)-galactose epitope. These mice confirm the importance of the galactose alpha(1,3)-galactose epitope in human xenoreactivity and the logic of continuing efforts to generate pigs that lack this epitope as a source of donor organs.
Stem Cells | 2004
Thomas C. Schulz; Scott Noggle; Gail Palmarini; Deb A. Weiler; Ian Lyons; Kate A. Pensa; Adrian Cuda Banda Meedeniya; Bruce Davidson; Nevin A. Lambert; Brian G. Condie
The use of human embryonic stem cells (hESCs) as a source of dopaminergic neurons for Parkinsons disease cell therapy will require the development of simple and reliable cell differentiation protocols. The use of cell cocultures, added extracellular signaling factors, or transgenic approaches to drive hESC differentiation could lead to additional regulatory as well as cell production delays for these therapies. Because the neuronal cell lineage seems to require limited or no signaling for its formation, we tested the ability of hESCs to differentiate to form dopamine‐producing neurons in a simple serum‐free suspension culture system. BG01 and BG03 hESCs were differentiated as suspension aggregates, and neural progenitors and neurons were detecz after 2–4 weeks. Plated neurons responded appropriately to electrophysiological cues. This differentiation was inhibited by early exposure to bone morphogenic protein (BMP)‐4, but a pulse of BMP‐4 from days 5 to 9 caused induction of peripheral neuronal differentiation. Real‐time polymerase chain reaction and whole‐mount immunocytochemistry demonstrated the expression of multiple markers of the midbrain dopaminergic phenotype in serum‐free differentiations. Neurons expressing tyrosine hydroxylase (TH) were killed by 6‐hydroxydopamine (6‐OHDA), a neurotoxic catecholamine. Upon plating, these cells released dopamine and other catecholamines in response to K+ depolarization. Surviving TH+ neurons, derived from the cells differentiated in serum‐free suspension cultures, were detected 8 weeks after transplantation into 6‐OHDA–lesioned rat brains. This work suggests that hESCs can differentiate in simple serum‐free suspension cultures to produce the large number of cells required for transplantation studies.
Current Biology | 2001
Renate Faast; Varaporn Thonglairoam; Thomas C. Schulz; Jacquie Beall; Julian R.E. Wells; Helen Taylor; Klaus I. Matthaei; Peter D. Rathjen; David J. Tremethick; Ian Lyons
Fundamental to the process of mammalian development is the timed and coordinated regulation of gene expression. This requires transcription of a precise subset of the total complement of genes. It is clear that chromatin architecture plays a fundamental role in this process by either facilitating or restricting transcription factor binding [1]. How such specialized chromatin structures are established to regulate gene expression is poorly understood. All eukaryotic organisms contain specialized histone variants with distinctly different amino acid sequences that are even more conserved than the major core histones [2]. On the basis of their highly conserved sequence, histone variants have been assumed critical for the function of mammalian chromatin; however, a requirement for a histone variant has not been shown in mammalian cells. Mice with a deletion of H1 degrees have been generated by gene targeting in ES cells, but these mice show no phenotypic consequences, perhaps due to redundancy of function [3]. Here we show for the first time that a mammalian histone variant, H2A.Z, plays a critical role in early development, and we conclude that this histone variant plays a pivotal role in establishing the chromatin structures required for the complex patterns of gene expression essential for normal mammalian development.
Stem Cells | 2003
Maisam Mitalipova; John D. Calhoun; David Wininger; Thomas Schulz; Scott Noggle; Alison Venable; Ian Lyons; Allan J. Robins; Steven L. Stice
Human pluripotent embryonic stem (ES) cells have important potential in regenerative medicine and as models for human preimplantation development; however, debate continues over whether embryos should be destroyed to produce human ES cells. We have derived four ES cell lines on mouse embryonic fibroblast cells in medium supplemented with basic fibroblast growth factor, human recombinant leukemia inhibitory factor, and fetal bovine serum. The source of these cell lines was poor‐quality embryos that in the course of routine clinical practice would have been discarded. After continuous proliferation in vitro for more than 12 months, these ES cell lines maintained their developmental potential to form trophoblast and somatic cells, including cardiac muscle and neuronal tissue.
Stem Cells | 2004
Xianmin Zeng; Takumi Miura; Yongquan Luo; Bhaskar Bhattacharya; Brian G. Condie; Jia Chen; Irene Ginis; Ian Lyons; Josef Mejido; Raj K. Puri; Mahendra S. Rao; William J. Freed
Human ES (hES) cell lines have only recently been generated, and differences between human and mouse ES cells have been identified. In this manuscript we describe the properties of two human ES cell lines, BG01 and BG02. By immunocytochemistry and reverse transcription polymerase chain reaction, undifferentiated cells expressed markers that are characteristic of ES cells, including SSEA‐3, SSEA‐4, TRA‐1‐60, TRA‐1‐81, and OCT‐3/4. Both cell lines were readily maintained in an undifferentiated state and could differentiate into cells of all three germ layers, as determined by expression of β‐tubulin III neuron‐specific molecule (ectoderm), cardiac troponin I (cardiomyocytes, mesoderm), and α‐fetoprotein (endoderm). A large‐scale microarray (16,659 genes) analysis identified 373 genes that were expressed at three‐fold or higher levels in undifferentiated BG01 and BG02 cells as compared with pooled human RNA. Ninety‐two of these genes were also highly expressed in four other hES lines (TE05, GE01, GE09, and pooled samples derived from GE01, GE09, and GE07). Included in the list are genes involved in cell signaling and development, metabolism, transcription regulation, and many hypothetical proteins. Two focused arrays designed to examine transcripts associated with stem cells and with the transforming growth factor‐β superfamily were employed to examine differentially expressed genes. Several growth factors, receptors, and components of signaling pathways that regulate embryonic development, in particular the nodal signaling pathway, were detected in both BG01 and BG02. These data provide a detailed characterization and an initial gene expression profile for the BG01 and BG02 human ES cell lines.
Transgenic Research | 2002
Sharon J. Harrison; Angelo Guidolin; Renate Faast; Lesley Crocker; Chris Giannakis; Anthony J. F. d'Apice; Mark B. Nottle; Ian Lyons
Pigs are currently considered the most likely source of organs for human xenotransplantation because of anatomical and physiological similarities to humans, and the relative ease with which they can be bred in large numbers. A severe form of rejection known as hyperacute rejection has been the major barrier to the use of xenografts. Generating transgenic pigs for organ transplantation is likely to involve precise genetic manipulation to ablate the α(1,3) galactosyltransferase (galT) gene. In contrast to the mouse, homologous recombination in livestock species to ablate genes is hampered by the inability to isolate functional embryonic stem cells. However, nuclear transfer using genetically targeted cultured somatic cells provides an alternative means to producing pigs deficient for galT. In this study we successfully produced galT+/− somatic porcine fetal fibroblasts using two approaches; positive negative selection (PNS) using an isogenic targeting construct, and with a promoterless vector using non-isogenic DNA.
Transgenic Research | 2001
Mark B. Nottle; K.A. Haskard; Paul J. Verma; Z.T Du; C. G. Grupen; Stephen M. McIlfatrick; Rodney J. Ashman; Sharon J. Harrison; Helen Barlow; Peter L. Wigley; Ian Lyons; Peter J. Cowan; Robert J. Crawford; Paul Tolstoshev; Martin J. Pearse; Allan J. Robins; Anthony J. F. d'Apice
A retrospective analysis of transgenesis rates obtained in seven pronuclear microinjection programs was undertaken to determine if a relationship existed between the amount of DNA injected and transgenesis rates in the pig. Logistic regression analysis showed that as the concentration of DNA injected increased from 1 to 10 ng/μl, the number of transgenics when expressed as a proportion of the number liveborn (integration rate) increased from 4% to an average of 26%. A similar relationship was found when the number of molecules of DNA injected per picolitre was analysed. No evidence was obtained to suggest either parameter influenced integration rate in mice when the same constructs were injected. The number of transgenics liveborn when expressed as a proportion of ova injected (efficiency rate), increased as DNA concentration increased up to 7.5 ng/μl and then decreased at 10 ng/μl for both species suggesting that at this concentration DNA (or possible contaminants) may have influenced embryo survival. The relationship between efficiency and the number of molecules injected per picolitre was complex suggesting that the concentration at which DNA was injected was a better determinant of integration and efficiency rates. In conclusion, the present study suggests that transgenes need to be injected at concentrations of between 5 and 10 ng/μl to maximise integration and efficiency rates in pigs.
BMC Developmental Biology | 2005
Alison Venable; Maisam Mitalipova; Ian Lyons; Karen Jones; Michael Pierce; Steven L. Stice
BackgroundPluripotent human embryonic stem cells (hESCs) have the potential to form every cell type in the body. These cells must be appropriately characterized prior to differentiation studies or when defining characteristics of the pluripotent state. Some developmentally regulated cell surface antigens identified by monoclonal antibodies in a variety of species and stem cell types have proven to be side chains of membrane glycolipids and glycoproteins. Therefore, to examine hESC surfaces for other potential pluripotent markers, we used a panel of 14 lectins, which were chosen based on their specificity for a variety of carbohydrates and carbohydrate linkages, along with stage specific embryonic antigen-4 (SSEA-4), to determine binding quantitation by flow cytometry and binding localization in adherent colonies by immunocytochemistry.ResultsEnriching cells for SSEA-4 expression increased the percentage of SSEA-4 positive cells to 98–99%. Using enriched high SSEA-4-expressing hESCs, we then analyzed the binding percentages of selected lectins and found a large variation in binding percentages ranging from 4% to 99% binding. Lycopersicon (tomato)esculetum lectin (TL), Ricinus communis agglutinin (RCA), and Concanavalin A (Con A) bound to SSEA-4 positive regions of hESCs and with similar binding percentages as SSEA-4. In contrast, we found Dolichos biflorus agglutinin (DBA) and Lotus tetragonolobus lectin (LTL) did not bind to hESCs while Phaseolus vulgaris leuco-agglutinin (PHA-L), Vicia villosa agglutinin (VVA), Ulex europaeus agglutinin (UEA), Phaseolus vulgaris erythro-agglutinin (PHA-E), and Maackia amurensis agglutinin (MAA) bound partially to hESCs. These binding percentages correlated well with immunocytochemistry results.ConclusionOur results provide information about types of carbohydrates and carbohydrate linkages found on pluripotent hESC surfaces. We propose that TL, RCA and Con A may be used as markers that are associated with the pluripotent state of hESCs because binding percentages and binding localization of these lectins are similar to those of SSEA-4. Non-binding lectins, DBA and LTL, may identify differentiated cell types; however, we did not find these lectins to bind to pluripotent SSEA-4 positive hESCs. This work represents a fundamental base to systematically classify pluripotent hESCs, and in future studies these lectins may be used to distinguish differentiated hESC types based on glycan presentation that accompanies differentiation.
Endothelium-journal of Endothelial Cell Research | 2003
Kara E. McCloskey; Ian Lyons; Raj R. Rao; Steven L. Stice; Robert M. Nerem
Embryonic stem (ES) cells serve as an excellent in vitro system for studying differentiation events and for developing methods of generating various specialized cells for future regenerative therapeutic applications. Two obstacles associated with using embryonic stem cells include (a) isolating homogeneous populations of differentiated cells and (b) obtaining terminally differentiated cell populations that are capable of proliferating further. Here, the authors describe methods in which they have overcome these two obstacles by generating highly purified populations (>96%) of actively proliferating endothelial cells from mouse ES cells. Briefly, 60,000 ES cells progress through three different stages of cell induction/expansion and two cell isolation procedures, generating over 300 million endothelial cells. These ES-derived endothelial cells display characteristics similar to vascular endothelial cells in that they express several common endothelial markers, they form two-dimensional (2D) tubelike structures as well as complex microvessels in three-dimensional (3D) collagen type I gels, and they retain the ability to reorganize their cytoskeleton in response to mechanical forces. Our findings indicate that it is possible to obtain proliferating populations of homogeneous endothelial cells from mouse ES cells without genetically manipulating the ES cells or coculturing with feeder cells.
Molecular Reproduction and Development | 2000
Paul J. Verma; Zhong-Tao Du; Lesley Crocker; Renate Faast; C. G. Grupen; Stephen M. McIlfatrick; Rodney J. Ashman; Ian Lyons; Mark B. Nottle
The in vitro development of porcine nuclear transfer embryos constructed using primary cultures from day 25 fetal fibroblasts which were either rapidly dividing (cycling) or had their cell‐cycle synchronized in G0/G1 using serum starvation (serum‐starved) was examined. Oocyte‐karyoplast complexes were fused and activated simultaneously and then cultured in vitro for seven days to assess development. Fusion rates were not different for either cell population. The proportion of reconstructed embryos that cleaved was higher in the cycling group compared to the serum‐starved group (79 vs. 56% respectively; P < 0.05). Development to the 4‐cell stage was not different using either population. Both treatments supported similar rates of development to the morula (1.5 vs. 7%, cycling vs. serum‐starved) and blastocyst stage (1.5 vs. 3%, cycling vs. serum‐starved). The blastocyst produced using cycling cells had a total cell number of 10. Total cell numbers for the three blastocysts produced serum‐starved cells were 22, 24, and 33. These blastocysts had inner cell mass numbers of 0, 15, and 4, respectively. Six hundred and thirty‐five nuclear transfer embryos reconstructed using serum‐starved cells were transferred to 15 temporarily mated recipients for 3–4 days. Of these, 486 were recovered (77% recovery rate) of which 106 (22%) had developed to the 4‐cell stage or later. These were transferred to a total of 15 recipients which were either unmated or mated. Seven recipients farrowed a total of 51 piglets. Microsatellite analysis revealed that none of these were derived from the nuclear transfer embryos transferred. Mol. Reprod. Dev. 57:262–269, 2000.